IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
38.41
-0.20 (-0.52%)
At close: Sep 18, 2026, 4:00 PM EDT
37.00
-1.41 (-3.67%)
After-hours: Sep 18, 2026, 7:30 PM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.71 billion as of September 18, 2026. Its market cap has increased by 73.02% in one year.
Market Cap
3.71B
Enterprise Value
2.49B
1-Year Change
73.02%
Ranking
Category
Stock Price
$38.41
ChartMarket Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.71B, an increase of 1,619.26%. That is a compound annual growth rate of 47.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.71B | 22.29% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 4.13B |
| AbCellera Biologics | 4.09B |
| Celcuity | 3.94B |
| Xenon Pharmaceuticals | 3.85B |
| Tango Therapeutics | 3.67B |
| Enliven Therapeutics | 3.62B |
| Tarsus Pharmaceuticals | 3.43B |
| Legend Biotech | 3.41B |